What: An analysis of over 30,000 women with type 2 diabetes found that those who got a GLP-1 medication, like Ozempic, were 27% less likely to develop new fibroids than women who just took metformin, a diabetes medication.
Key line: “In women with type 2 diabetes, GLP-1 receptor agonists may protect against new-onset uterine fibroids compared to both metformin and insulin,” Hsieh said. “We recommend further research, including prospective cohorts and basic research, to understand the underlying therapeutic mechanisms.”
Source: American Society for Reproductive Medicine // https://www.healio.com/news/womens-health-ob-gyn/20241028/glp1-drugs-may-reduce-uterine-fibroid-risk-for-women-with-type-2-diabetes